Exhibit 99.1 amwell 2 AMWELL ANNOUNCES RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2024 BOSTON, July 31, 2024 – Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, today announced financial results for the second quarter of 2024. "In Q2, we drove progress on all fronts. We continued the deployment of our solution for the U.S. Military Health System and our ongoing rigorous cost alignment efforts resulted in an improved outlook for 2024 adjusted EBITDA," said Ido Schoenberg, M.D. chairman and CEO of ...

Boston, July 31, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for the second quarter ended June 30, 2024. Visit Amwell’s investor relations website at investors.amwell.com to view the second quarter 2024 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, Wednesday, July 31. The call can be accessed via a live audio w ...

Wall Street expects a year-over-year increase in earnings on lower revenues when American Well Corporation (AMWL) reports results for the quarter ended June 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on July 31, 2024, might help the stock move higher if these key numbers are better ...

Boston, July 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, will report its second quarter 2024 operating results on Wednesday, July 31. Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The audio webcast can be accessed by visiting the Investors section of the company's website. Alter ...

Boston, June 28, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a small-cap growth healthcare company and a leading provider of healthcare software as a service, today announced that its Board of Directors (the "Board") has approved a 1-for-20 reverse stock split ("Reverse Split") of its Class A common stock, Class B common stock and Class C common stock (collectively, the "Common Stock"), that is expected to become effective on July 10, 2024 at 5:00 p.m. EDT. The shares of the Company's Class A common stock ...

Boston, June 28, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a small-cap growth healthcare company and a leading provider of healthcare software as a service, today announced that its Board of Directors (the “Board”) has approved a 1-for-20 reverse stock split (“Reverse Split”) of its Class A common stock, Class B common stock and Class C common stock (collectively, the “Common Stock”), that is expected to become effective on July 10, 2024 at 5:00 p.m. EDT. The shares of the Company’s Class A common stoc ...

Group 1 - Amwell appointed Ricky Goldwasser to its Board of Directors effective June 13, 2024, to enhance its focus on profitability and operational efficiency [1][2] - Goldwasser has a strong financial background with 15 years at Morgan Stanley and experience in leading successful IPOs, including Amwell's [2] - She replaces Deval Patrick, who served on the board since 2015 and contributed significantly to Amwell's telehealth initiatives [3] Group 2 - Amwell is a leading hybrid care delivery platform in the U.S. and globally, connecting providers, payers, patients, and innovators to improve healthcare access and quality [4] - The company supports over 50 health plans, representing more than 100 million covered lives, and aims to transform healthcare through hybrid care delivery [4]

Boston, June 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's Board of Directors, effective June 13. “Ricky brings to our board a deep financial background that makes her an invaluable addition as we focus on Amwell’s path to profitability. Ricky’s strong voice coupled with her impressive track record will help guide Amwell as we strive for greater efficiencies, optimized cash flow and profitable growt ...

Company Transition - Amwell co-founder Roy Schoenberg transitions from president and co-CEO to Executive Vice Chairman of the Board [1] - Ido Schoenberg assumes the role of sole Chief Executive Officer of Amwell [1] Leadership Impact - Roy Schoenberg has been instrumental in promoting digital healthcare since co-founding Amwell in 2006, advocating for the democratization of healthcare access through technology [2] - Under his leadership, Amwell's platform grew to over 100,000 active clinicians and millions of patients globally [2] Future Direction - The company is shifting focus from R&D investment to operational efficiency, cash flow optimization, and profitable growth [3] - Roy Schoenberg emphasizes the importance of leveraging new technology to achieve operational and clinical goals [3]

American Well Corporation (NYSE:AMWL) Q1 2024 Earnings Call Transcript May 1, 2024 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Robert Shepardson - Chief Financial Officer Conference Call Participants Charles Rhyee - TD Cowen Craig Hettenbach - Morgan Stanley Jessica Tassan - Piper Sandler Jailendra Singh - Truist Securities Matthew Shea - Needham & Company Stan Berenshteyn - Wells Fargo Securities Hanna Lee - Bank of America Jen ...